Sophie KORNOWSKI-BONNET

President, Roche SAS

Finding innovative solutions for serious medical problems is what being a healthcare company is about. For Roche, our efforts aim to enable healthcare to be tailored more closely to patients’ needs. As both a diagnostics and a pharmaceuticals company, we are ideally placed to contribute to progress towards more personalized healthcare, opening up new ways to prevent, diagnose and treat illness. Roche is committed to finding the world’s best scientific ideas wherever they are and developing them into medicines. Roche maintains a vast network of collaborative and consultative relationships with leading academic researchers around the world in many different scientific fields. Roche always looks forward to the challenge of transforming key partnerships into strategic alliances. Real rewards come through partnerships that work in the long run. Because therapeutic innovation is our “Raison d’Etre”, because Roche is the world leading biotech company, because science and knowledge are at the very origin of everything we undertake to better meet patients’ vital needs and expectations, because new generations of highly talented, motivated and future-ready colleagues will have to pave our way ahead : we firmly believe in and are fully committed to tightly partnering with the ESSEC Chair of Therapeutic Innovation, its students, professors and their upcoming endeavors.